Preclinical investigation of the pharmacokinetics, metabolism, and protein and red blood cell binding of DRDE-07: a prophylactic agent against sulphur mustard

[1]  P. Verma,et al.  HPLC DETERMINATION OF DRDE-07 IN MICE PLASMA: PROBABLE ANTIDOTE FOR SULFUR MUSTARD TOXICITY , 2013 .

[2]  R. Vijayaraghavan,et al.  Quantitative estimation of DRDE-07 in mice urine using ion-paired reversed-phase high-performance liquid chromatography , 2012 .

[3]  Yong Zhang,et al.  PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel , 2010, Comput. Methods Programs Biomed..

[4]  F. Lee,et al.  Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL , 2008, Cancer Chemotherapy and Pharmacology.

[5]  K. P. Madhusudanan,et al.  In Vitro and In Vivo pharmacokinetic studies of bulaquine (analogue of primaquine), a novel antirelapse antimalarial, in rat, rabbit and monkey—highlighting species similarities and differences , 2007, Biopharmaceutics & drug disposition.

[6]  L. Granero,et al.  General Treatment of the Enterohepatic Recirculation of Drugs and Its Influence on the Area Under the Plasma Level Curves, Bioavailability, and Clearance , 1992, Pharmaceutical Research.

[7]  R. Vijayaraghavan,et al.  In vivo protection by amifostine and DRDE-07 against sulphur mustard toxicity , 2002, Human & experimental toxicology.

[8]  Younggil Kwon,et al.  Handbook of Essential Pharmacokinetics, Pharmacodynamics and Drug Metabolism for Industrial Scientists , 2001, Springer US.

[9]  R. Tulsawani,et al.  Protective effects of amifostine and its analogues on sulfur mustard toxicity in vitro and in vivo. , 2001, Toxicology and applied pharmacology.

[10]  R. C. Malhotra,et al.  Prophylactic efficacy of amifostine and its analogues against sulphur mustard toxicity. , 2001, Toxicology.

[11]  Pravin Kumar,et al.  Treatment for Sulphur Mustard Poisoning -A Review , 1998 .

[12]  D. Hinshaw,et al.  Sulfur mustard induces apoptosis and necrosis in endothelial cells. , 1996, Toxicology and applied pharmacology.

[13]  R. Trapp,et al.  A Commentary on the Chemical Weapons Convention , 1994 .

[14]  L. Piddock,et al.  Accumulation and killing kinetics of fifteen quinolones for Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa. , 1993, The Journal of antimicrobial chemotherapy.

[15]  A Z Momeni,et al.  Skin manifestations of mustard gas. A clinical study of 535 patients exposed to mustard gas. , 1992, Archives of dermatology.

[16]  W. Eisenmenger,et al.  Clinical and morphological findings on mustard gas [bis(2-chloroethyl)sulfide] poisoning. , 1991, Journal of forensic sciences.

[17]  M A Dunn,et al.  Medical defense against blistering chemical warfare agents. , 1991 .

[18]  B. Papirmeister,et al.  Medical Defense Against Mustard Gas: Toxic Mechanisms and Pharmacological Implications , 1991 .

[19]  L. Piddock,et al.  An investigation of the hydrophobicity of the quinolones. , 1986, The Journal of antimicrobial chemotherapy.

[20]  William P. Purcell,et al.  Strategy of drug design: A guide to biological activity , 1973 .

[21]  Adrien Albert,et al.  The determination of ionization constants : a laboratory manual , 1971 .